Insider Selling: Medical Transcription Billing Corp (NASDAQ:MTBC) Director Sells 8,000 Shares of Stock

Medical Transcription Billing Corp (NASDAQ:MTBC) Director John N. Daly sold 8,000 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $4.63, for a total transaction of $37,040.00. Following the completion of the sale, the director now owns 124,900 shares of the company’s stock, valued at approximately $578,287. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

NASDAQ:MTBC traded down $0.03 during mid-day trading on Friday, reaching $4.62. The stock had a trading volume of 38,300 shares, compared to its average volume of 56,282. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.01 and a current ratio of 2.05. The firm has a market capitalization of $57.88 million, a price-to-earnings ratio of -7.83 and a beta of 1.62. Medical Transcription Billing Corp has a twelve month low of $3.25 and a twelve month high of $5.65. The business has a 50 day simple moving average of $4.82 and a 200 day simple moving average of $4.77.

Medical Transcription Billing (NASDAQ:MTBC) last announced its quarterly earnings data on Wednesday, August 7th. The technology company reported ($0.19) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.19). The firm had revenue of $16.75 million during the quarter, compared to the consensus estimate of $15.33 million. Medical Transcription Billing had a negative net margin of 9.21% and a negative return on equity of 17.50%. As a group, sell-side analysts expect that Medical Transcription Billing Corp will post -0.48 earnings per share for the current year.

A hedge fund recently raised its stake in Medical Transcription Billing stock. Dimensional Fund Advisors LP raised its stake in Medical Transcription Billing Corp (NASDAQ:MTBC) by 33.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 37,273 shares of the technology company’s stock after buying an additional 9,364 shares during the period. Dimensional Fund Advisors LP owned approximately 0.32% of Medical Transcription Billing worth $142,000 at the end of the most recent reporting period. 10.02% of the stock is currently owned by institutional investors.

Separately, HC Wainwright restated a “buy” rating on shares of Medical Transcription Billing in a research report on Thursday, May 9th.

About Medical Transcription Billing

Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform.

Read More: Why do corrections happen?

Insider Buying and Selling by Quarter for Medical Transcription Billing (NASDAQ:MTBC)

Receive News & Ratings for Medical Transcription Billing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing and related companies with MarketBeat.com's FREE daily email newsletter.